. Endothelin-1-induced contraction in veins is independent of hydrogen peroxide. Am J Physiol Heart Circ Physiol 289: H1115-H1122, 2005. First published May 20, 2005; doi:10.1152/ajpheart.00086.2005.-Reactive oxygen species (ROS), such as superoxide and H 2O2, are capable of modifying vascular tone, although the response to ROS can vary qualitatively among vascular beds, experimental procedures, and species. Endothelin-1 (ET-1) induces superoxide production, which can be dismutated to H 2O2. The RhoA/Rho kinase pathway partially mediates ET-1-induced contraction and recently was implicated in superoxide-induced contraction. We hypothesized that H 2O2, not superoxide, mediates venous ET-1-induced contraction. Rat thoracic aorta and vena cava contracted to exogenously added H 2O2 (1 M-1 mM) [maximum aortic contraction ϭ 10 Ϯ 3% of phenylephrine (10 M) contraction; maximum venous contraction ϭ 85 Ϯ 13% of
venous contractility; reactive oxygen species REACTIVE OXYGEN SPECIES (ROS), specifically superoxide and H 2 O 2 , are capable of modifying vascular tone in complex manners. Some vascular beds contract to ROS (24) , whereas others relax in the presence of ROS (30) . In rat pulmonary artery and aorta, H 2 O 2 and other oxidants induce contraction, and in rat pulmonary artery this contraction to H 2 O 2 is independent of intracellular Ca 2ϩ influx (19) . Multiple pathways appear to be involved in H 2 O 2 -induced arterial contraction. For example, the cyclooxygenase pathway working via thromboxane A 2 receptors mediates H 2 O 2 -induced contraction in rat aorta (6, 20) , a tyrosine kinase-mediated pathway is involved in rat pulmonary artery contraction to H 2 O 2 (8) , and serine esterases that activate PLC are involved in rabbit pulmonary artery contraction to H 2 O 2 (24) .
Endothelin-1 (ET-1) stimulates the production of ROS. Specifically, ET-1 induces NADPH oxidase to stimulate production of superoxide from endothelial and smooth muscle cells (3) . ET A receptor blockade, but not ET B receptor blockade, reduces elevated superoxide levels in the aorta and vena cava from DOCA-salt hypertensive rats and reduces ET-1-stimulated superoxide production, suggesting that the ET A receptor couples to superoxide production (12, 13) . Elevated ROS levels are important in hypertension because chronic administration of apocynin, which prevents NADPH oxidase assembly, attenuates the increase in blood pressure in the DOCA-salt rat (1) . This has been largely attributed to decreases in arterial tone. The precise relationship between venous contractility and blood pressure is not fully understood. Understanding signaling mechanisms underlying venous contractility, one goal of this present work, will provide more information about venous mechanisms in determining blood pressure.
The Rho kinase pathway is involved in ET-1-induced contraction of rabbit basilar artery (16) and is involved in ET-1-induced Ca 2ϩ sensitization in rabbit cavernosal smooth muscle (29) . Superoxide-induced contraction in the rat thoracic aorta occurs via activation of the Rho kinase pathway (9) . To our knowledge, it is unknown whether H 2 O 2 -induced contraction can occur via activation of the Rho kinase pathway. Superoxide is extremely reactive and has a small diffusion distance compared with H 2 O 2 , which is readily diffusible and easily crosses membranes (31) . Thus we hypothesize that the more stable ROS H 2 O 2 is a likely mediator of smooth muscle contraction and other ROS signaling. We envision ET-1 stimulating NADPH oxidase to produce superoxide, which dismutates into H 2 O 2 that can activate Rho kinase, causing myosin phosphatase phosphorylation and inactivation, resulting in venous contraction.
MATERIALS AND METHODS
Isolated tissue bath protocol. The thoracic aorta and thoracic vena cava were dissected from anesthetized male Sprague-Dawley rats (pentobarbital sodium, 60 mg/kg ip) and placed in a physiological salt solution (PSS) containing (in mM) 130 NaCl, 4.7 KCl, 1.18 KH 2PO4, 1.17 MgSO4 ⅐ 7H2O, 1.6 CaCl2 ⅐ 2H2O, 14.9 NaHCO3, 5.5 dextrose, and 0.03 CaNa2EDTA (pH 7.2). Tissues were cleaned of extraneous tissue and fat, cut into 3 to 4-mm rings, and hung between two wire hooks with one end attached to a stationary glass rod and the other end attached to a force transducer. The tissues were placed into warmed (37°C), aerated (95% O 2-5% CO2), 30-ml isolated tissue baths for measurement of isometric contractile force.
Each ring was placed under optimum resting tension (previously determined 4,000 mg for rat aorta, 1,000 mg for rat vena cava) and allowed to equilibrate for 1 h with frequent buffer changes. Arteries were challenged with a maximal concentration of the ␣-adrenergic agonist phenylephrine (PE; 10 M), and veins were challenged with a maximal concentration of the ␣-adrenergic agonist norepinephrine (NE; 10 M) to initiate a maximal contraction, and tissues were washed repeatedly until tone returned to baseline. Veins were challenged with NE because PE did not elicit a reproducible contraction in these tissues. Arteries were challenged with PE to relate current findings to previous studies. In some studies, the endothelium of the aorta was removed by gently rubbing the intima of the aortic rings with a metal wire. Endothelial removal was verified as a Ͻ20% relaxation to acetylcholine (ACh, 1 M) in PE (10 nM)-contracted aorta, and endothelial integrity was verified by a Ͼ80% relaxation to ACh (1 M) in PE (10 M)-or NE (10 M)-contracted aorta and vena cava, respectively. Afterward, tissues were again washed until baseline was reached, and then a cumulative concentration response curve to an agonist was performed or the tissues were incubated with antagonist or vehicle for 1 h before performing cumulative concentration response curves to ET-1 or exogenous H 2O2.
We observed that high concentrations of catalase (2,000 U/ml) caused excess bubble formation that interfered with measuring contraction. Thus Antifoam B (0.001%), a silicon-based emulsifier, was added to control and catalase (2,000 U/ml)-incubated baths to reduce bubbles. After cumulative H2O2 concentration response curves were performed, the vena cava was washed several times with PSS and a subsequent NE (10 M) challenge was performed to assess tissue viability after exposure to millimolar concentrations of H2O2.
Measurement of arterial and venous H2O2 production. H2O2 production from the rat aorta and vena cava was assessed by using an Amplex Red H2O2 assay kit (Molecular Probes, Eugene, OR). Threeto four-millimeter segments of the thoracic aorta and thoracic vena cava were dissected from rats; cleaned of fat, connective tissue, and blood; and then incubated in 500 l of Krebs-HEPES buffer containing (in mM) 20 HEPES, 119 NaCl, 4.6 KCl, 1.0 MgSO4 ⅐ 7H2O, 0.15 Na2HPO4, 0.4 KH2PO4, 5 NaHCO3, 1.2 CaCl2, and 5.5 dextrose at 37°C for 1 h. Antagonists or vehicle was incubated during the 1-h Krebs-HEPES buffer equilibration. Krebs-HEPES buffer was carefully removed, and 200 l of Amplex Red reaction solution was added to the tissues. Tissues were incubated with ET-1 (1, 10, and 100 nM) or ET-1 (100 nM) plus antagonists [atrasentan (10 nM); ETA receptor antagonist BQ-788 (100 nM); ETB receptor antagonist or diethyldithiocarbamate (DDC, 10 mM) a SOD inhibitor] for 4 h at 37°C. Li et al. (12, 13) previously determined that maximal ET-1-stimulated superoxide production occurred after a 4-h incubation; thus we chose to measure ET-1-stimulated H2O2 production after a 4-h incubation. The Amplex Red solution was then transferred to a 96-well plate, and fluorescence emission was measured (excitation ϭ 544 nm; emission ϭ 584 nm) on a SpectraMax Gemini plate reader (Molecular Devices, Sunnyvale, CA) by using SoftMaxPro software. A standard curve with the use of known H2O2 concentrations was performed with each experiment and was used to determine H2O2 concentration. After each experiment, aortic and venous segments were homogenized, and protein concentrations were determined by using the bicinchoninic assay for protein determination. H2O2 production from the rat aorta and vena cava is represented as nanomole per milligram protein or as a percentage of control response.
Measurement of arterial and venous superoxide production. Superoxide production in the rat aorta and vena cava was assessed by using lucigenin-enhanced chemiluminescence as described previously (12, 13) . Briefly, 4-mm segments of thoracic aorta and vena cava were dissected from rats; cleaned of fat, connective tissue, and blood; and then equilibrated in 950 l of Krebs-HEPES buffer for 30 min at 37°C. DDC (10 mM) was then added to the buffer with segments of tissue and incubated for 4 h at 37°C. Tissues were then transferred to a new tube containing 1 ml of Krebs-HEPES buffer with lucigenin (5 M) and incubated at 37°C for 10 min, and then 10 luminescence readings were measured by using a luminometer (TD-20/20 Luminometer, Turner Designs, Sunnyvale, CA). 4,5-Dihydroxy-1,3-benzenedisulfonic acid disodium salt (Tiron, 10 mM) was added to the tubes, and after a 10-min incubation, 10 luminescence readings were taken. Tissues were blotted dry and weighed. The superoxide signal from the tissues was determined as the average difference in luminescence before and after the addition of Tiron, and superoxide levels [in nmol superoxide/(min ⅐ mg)] were determined by using a standard curve generated with xanthine-xanthine oxidase.
Data analysis. Data are presented as means Ϯ SE and as a percentage of the initial response to PE (10 M for arteries) or NE (10 M for veins) for the number of animals indicated in parentheses. When two groups were compared, the appropriate Student's t-test was used. When more than two groups were compared, ANOVA was performed by using Bonferroni's post hoc test. When H2O2 levels were compared, repeated measured ANOVA was performed with Bonferroni's post hoc test. In all cases, a P value Յ0.05 was considered statistically significant.
Chemicals. ACh, 3-aminotriazole (3-AT), Antifoam B emulsion, catalase, polyethylene glycol (PEG)-catalase, DDC, H 2O2 (30%), lucigenin, NE, PE, and Tiron were solubilized in water and purchased from Sigma Chemical (St. Louis, MO). ET-1 was obtained from Peninsula Laboratories (Belmont, CA) and solubilized in deionized water. Y-27632 was purchased from BioMol Research Laboratories (Plymouth Meeting, PA) and solubilized in deionized water. BQ-788 was purchased from Peninsula Laboratories and was solubilized in dimethyl sulfoxide (DMSO). Atrasentan (solubilized in DMSO) was a gift from Abbott Laboratories. Fig. 3A and 2 ,000 U/ml, Fig. 3B ) nor the cell-permeable PEG-catalase (163 and 326 U/ml, Fig. 3C ) significantly reduced venous ET-1-induced contraction, suggesting that H 2 O 2 is not a downstream effector mediating ET-1-induced venous contraction. PEG-catalase (326 U/ml) potentiated maximal ET-1-induced contraction, suggesting that ET-1-stimulated H 2 O 2 may actually function as a venous vasodilator. However, inhibition of catalase activity with 3-AT (50 mM) had no effect on venous ET-1-induced contraction (Fig. 3D) , suggesting that endogenous H 2 O 2 does not cause venous relaxation under these conditions.
RESULTS

Rat thoracic aorta and vena cava contract to exogenous
We were concerned that millimolar concentrations of H 2 O 2 would cause vessel injury because several groups reported observing reductions in contractility after exposure to H 2 O 2 (1 mM) (4, 15, 21) . We compared initial NE (10 M) contraction in the vena cava at the beginning of an experiment to a subsequent NE (10 M) contraction after cumulative exogenous H 2 O 2 concentration response curves had been performed, and we considered H 2 O 2 -induced vessel injury to be a reduction in NE (10 M) contraction compared with the initial NE contraction. Catalase (100 U/ml) or PEG-catalase (163 U/ml) exposure before cumulative H 2 O 2 concentration response curves prevented H 2 O 2 -mediated reductions in NE contraction (Fig. 4) , suggesting that catalase protected the vena cava from H 2 O 2 -induced vessel injury. Incubation with 3-AT (50 mM), a catalase inhibitor, did not prevent H 2 O 2 -mediated reductions in NE contraction as did catalase but further depressed subsequent NE contraction after H 2 O 2 exposure (Fig. 4) (Fig. 5A) , whereas basal superoxide production was five times lower in the vena cava than in the aorta [vena cava, 0.06 Ϯ 0.05 nmol superoxide/(min⅐mg); aorta, 0.32 Ϯ 0.03 nmol superoxide/(min⅐mg)] (Fig. 5B) . Both venous and arterial H 2 O 2 were superoxide derived because incubation with DDC, a superoxide dismutase inhibitor, significantly reduced basal H 2 O 2 (Fig. 5A ). ET-1 (100 nM) stimulated a significant increase in H 2 O 2 production in the vena cava but not in the aorta (Fig. 5C) , although the ET-1-induced increase in H 2 O 2 in the vena cava did not appear to be concentration dependent within the concentrations tested (Fig. 6A) . ET-1-induced increases in H 2 O 2 production were reduced by either ET A or ET B receptor antagonism with the use of atrasentan (30 nM) or BQ-788 (100 nM), respectively, whereas neither of these drugs had any effect on basal venous H 2 O 2 levels (Fig. 6B) .
DISCUSSION
ROS are involved in the pathophysiology of ET-1-dependent
hypertension. H 2 O 2 and other ROS are vasoactive and can modulate blood vessel contractility. Several groups have reported elevations in arterial tissue levels of ET-1 and arterial production of superoxide in endothelin-dependent models of hypertension, such as DOCA-salt hypertension (8, 12, 25) . The increase in arterial superoxide production in DOCA-salt hypertension is mediated by increased NADPH oxidase activity (1, 12) and is attenuated by ET A receptor blockade (12) . ET-1 infusion increased blood pressure and increased vascular superoxide (5, 23) , suggesting that ET-1 is directly or at least closely involved with increasing superoxide in hypertension. However, there are conflicting results regarding the role of ROS (superoxide and/or H 2 O 2 ) in hypertension induced by Fig. 3. H2O2 is not involved in venous ET-1-induced contraction because neither catalase [100 U/ml (A) and 2,000 U/ml (B), n ϭ 7 animals] nor polyethylene glycol (PEG)-catalase [163 and 326 U/ml (C), n ϭ 5 animals] reduced venous ET-1-induced contraction. Antifoam B (0.001%) was used to prevent excessive bubble formation with catalase (2,000 U/ml). Catalase inhibitor 3-aminotriazole [3-AT, 50 mM (D), n ϭ 5 animals] had no effect on maximal venous ET-1-induced contraction. Points represent means Ϯ SE. *P Ͻ 0.05 represents a statistically significant difference from control. Experiments were performed in normal rat vena cava with endothelium intact.
ET-1 infusion. In a study performed by Sedeek et al. (23), 4-hydroxy-2,2,6,6-tetramethylpiperidinoxyl (Tempol, a SOD mimetic) reduced ET-1-induced increases in blood pressure and ET-1-induced increases in vascular superoxide, suggesting that ET-1-stimulated ROS directly have a pressor response. In a conflicting study performed by Elmarakby et al. (5) , neither Tempol nor apocynin (an inhibitor of NADPH oxidase assembly) reduced ET-1-induced increases in blood pressure, but both Tempol and apocynin reduced vascular superoxide production and other markers of oxidative stress, suggesting that ET-1-stimulated ROS do not directly increase blood pressure but may be a result of elevated blood pressure. Our data suggest that endogenous H 2 O 2 production does not mediate ET-1-induced contraction or relaxation and thus is likely not involved in the pressor response to ET-1.
H 2 O 2 can modulate vascular tone. Most of the studies pertaining to the ability of H 2 O 2 to modify vascular tone have been performed in arteries, although one study has been performed in rat pulmonary veins (19) . H 2 O 2 elicits vascular contraction and relaxation with the response depending on the vascular bed studied and experimental conditions. Rat aorta (6, 21) , rat pulmonary arteries and veins, abdominal aorta, and inferior vena cava contract to H 2 O 2 (1 M-1 mM) (19) . We observed a concentration-dependent contraction to H 2 O 2 (1 M-1 mM) in thoracic aorta and vena cava. We did not perform experiments to examine the ability of H 2 O 2 to cause relaxation. The H 2 O 2 -induced contraction observed in thoracic vena cava was larger in magnitude than that in the aorta when this contraction was represented as a percentage of initial adrenergic agonist challenge. Our experiments were performed with the endothelium intact so as to more closely mimic how H 2 O 2 might affect contractility in vivo, and we did not observe any significant difference in aortic H 2 O 2 -induced contraction with endothelial removal, suggesting that aortic contraction to H 2 O 2 is not affected by release of endothelium-derived factors but is due to H 2 O 2 acting directly on vascular smooth muscle cells. However, Rodriguez-Martinez et al. (21) observed that endothelial removal enhanced aortic contraction to H 2 O 2 . Discrepancies in the magnitude of aortic H 2 O 2 -induced contraction may be due to differences in the strain of rat used.
Rho kinase pathway: the link between H 2 O 2 -and ET-1-induced contraction?
As an initial step to determine whether H 2 O 2 was involved in ET-1-induced contraction, we examined the role of the Rho kinase pathway as a potential point of convergence of signaling in H 2 O 2 and ET-1-induced contraction. Contraction via the RhoA/Rho kinase pathway involves Ca 2ϩ sensitization such that small increases in intracellular Ca 2ϩ will elicit smooth muscle contraction (26) . Recently, Jin et al. (9) reported that superoxide-induced contraction of the rat thoracic aorta occurred via the Rho kinase pathway as xanthine-xanthine oxidase-induced contraction was reduced by the Rho kinase inhibitor Y-27632. Catalase only partially reduced xanthine-xanthine oxidase-induced contraction; thus Jin et al. (9) concluded that superoxide, as opposed to H 2 O 2 , mediated contraction in arteries via activation of the Rho kinase pathway. An alternative means by which superoxide and H 2 O 2 may cause contraction is via superoxide and H 2 O 2 reducing bioavailable nitric oxide (NO) to form peroxynitrite and hydroxyl radical (17) , respectively. NO inhibits Ca 2ϩ sensitization and actin reorganization induced by RhoA (22) . Functionally, NOmediated vasodilation of rat aorta partially occurs via NO inhibition of Rho kinase as Y-27632, a Rho kinase inhibitor, is less effective in the absence of NO, suggesting that there is more Rho kinase activity in the absence of NO (2) . The Rho kinase-specific inhibitor Y-27632 (1-10 M) significantly inhibited venous H 2 O 2 -induced contraction, suggesting that the RhoA/Rho kinase pathway is likely an important mechanism for H 2 O 2 -induced contraction.
The Rho kinase pathway has been implicated in ET-1-induced contraction (16) , the high blood pressure of the DOCA-salt rat (28) , and in the pathogenesis of human essential hypertension (14) . The Rho kinase inhibitor Y-27632 (10 M) significantly reduced venous contraction to ET-1, suggesting that the Rho kinase pathway is involved in venous ET-1-induced contraction. The concentration of Y-27632 used (10 M) has been shown to completely reduce xanthine-xanthine oxidase-induced contraction in rat thoracic aorta, and Y-27632 (1 M) did not affect PKC-mediated contraction (9) . From the above experiments the Rho kinase pathway seemed to be a logical point of convergence for H 2 O 2 and ET-1-induced contraction, and we hypothesized that ET-1 could stimulate superoxide and H 2 O 2 production, which could in turn activate the Rho kinase pathway to mediate ET-1-induced contraction.
H 2 O 2 does not mediate ET-1-induced contraction in rat thoracic vena cava. To determine whether endogenous H 2 O 2 production mediated venous ET-1-induced contraction, we examined the effect of catalase, a H 2 O 2 scavenger, on ET-1-induced contraction. We did not observe a reduction in ET-1-induced contraction in the presence of catalase (100 and 2,000 U/ml) or PEG-catalase (163 and 326 U/ml), suggesting that in normal vena cava, endogenous H 2 O 2 does not mediate ET-1-induced contraction. PEG-catalase (326 U/ml) significantly potentiated maximal ET-1-induced contraction, suggesting that endogenous venous H 2 O 2 production may play a vasodilatory role. However, 3-AT, a catalase inhibitor, had no effect on maximal ET-1-induced contraction. These data suggest that ET-1-induced superoxide and H 2 O 2 production do not have immediate contractile effects and are consistent with the observation that Tempol does not markedly reduce ET-1-induced contraction in vena cava from normotensive rats (13) .
To further dissociate ET-1-induced ROS production from ET-1-induced contraction, we compared basal endogenous H 2 O 2 production to ET-1 (100 nM)-stimulated H 2 O 2 production in the rat thoracic aorta and vena cava. We observed that the vena cava had significantly more basal endogenous H 2 O 2 than the aorta and that ET-1 increased H 2 O 2 production in the vena cava but not in the aorta. One possible explanation as to why we did not observe an ET-1-mediated increase in aortic H 2 O 2 production could be because the Amplex Red H 2 O 2 assay kit was not sensitive enough to measure comparatively small increases in H 2 O 2 , and this is a noted limitation in the interpretation of these experiments. Another explanation is that the low contractile reactivity to H 2 O 2 and the low basal H 2 O 2 production in the aorta may be indicative of generally lower H 2 O 2 -producing capabilities and is reflected in our inability to Fig. 5 . A: basal H2O2 production was significantly higher in veins compared with arteries, and this H2O2 production was superoxide derived as incubation with diethyldithiocarbamate (DDC, 10 mM) significantly reduced H2O2 production. Data are represented as nmol of H2O2/mg protein. n ϭ 9 -14 animals. *P Ͻ 0.05 represents a statistically significant difference in the presence of DDC; #P Ͻ 0.05 represents a statistically significant difference between aorta and vena cava. B: basal superoxide production (measured with lucigeninenhanced chemiluminescence) was significantly higher in arteries compared with veins. Data are represented as nmol of superoxide/(min ⅐ mg). n ϭ 7-9 animals. *P Ͻ 0.05 represents a statistically significant difference between aorta and vena cava. C: ET-1 increased endogenous H2O2 production in veins but not arteries. Data are represented as a percentage of the control response (n ϭ 9 -14). *P Ͻ 0.05 represents a statistically significant difference in the presence of ET-1.
measure ET-1-induced increases in H 2 O 2 . Future studies using the intracellular fluorescent ROS probe dichlorodihydrofluorescein (DCFH) may be useful for comparing the spatial relationship of arterial and venous H 2 O 2 production, but such experiments are not feasible to perform in aortic and venous tissue sections because of high elastin autofluorescence. Also, DCFH is not a specific probe for H 2 O 2 but will also fluorescence in the presence of hypochlorous acid and peroxynitrite (27) .
Not surprisingly, the H 2 O 2 in rat thoracic aorta and vena cava was primarily derived from superoxide as DDC, a Cu/ ZnSOD inhibitor, significantly reduced basal H 2 O 2 levels in the aorta and vena cava, although other mechanisms of H 2 O 2 production are likely present. Whereas rat thoracic aorta and vena cava appear to have similar sources of H 2 O 2 , one report (7) suggests that the source of superoxide differs in human arteries and veins. Guzik et al. (7) report that NADPH oxidase is the major source of superoxide in human saphenous veins, whereas xanthine oxidase is the primary source of superoxide in human internal mammary artery. When aortic and venous levels of superoxide were measured by using lucigenin-enhanced chemiluminescence, we observed that rat thoracic aorta has approximately five times as much superoxide as rat thoracic vena cava. It is possible that arteries compared with veins have lower SOD enzymatic activity or that catalase activity is high in arteries and low in veins such that H 2 O 2 levels remain low in arteries but high in veins. Perhaps the complement of antioxidant enzymes in arteries and veins differs such that ET-1 induces the production of different ROS in arteries and veins; specifically, in rat arteries superoxide is predominantly formed, whereas in rat veins, H 2 O 2 is predominantly formed. Whether the antioxidant systems and their activities differ in Fig. 6 . A: ET-1 (100 nM) increased venous H2O2 production, though the increase in H2O2 was not dependent on ET-1 concentration (n ϭ 5-7). B: ET-1 (100 nM)-induced increases in venous H2O2 were reduced by ETA receptor blockade (30 nM atrasentan) or ETB receptor blockade (100 nM BQ-788), whereas atrasentan and BQ-788 alone had no effects on control H2O2 production. Data are represented as a percentage of control response (n ϭ 5-6). *P Ͻ 0.05 represents a statistically significant difference from control.
